Search Results

HOME > SEARCH > SEARCH RESULTS

Refine by Audience:

Your search for pilot research returned 275 results.

Selected filters: Technologists

Physicians

Displaying 51 to 60 of 275 records
Sort by: Page: << Prev 3… 4… 5… 6… 7… 8… 9… Next >>

JNM Publishes Consensus Statement on Patient Selection and Appropriate Use of Lu-177 PSMA-617 Radionuclide Therapy – Sep 1, 2023
SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer (mCRPC) patients being treated with Lu-177 PSMA radionuclide therapy.
Therapy COE 2023 Young Investigator Awards – Aug 30, 2023
Winners of the 2023 Young Investigator Awards for the Therapy Center of Excellence
New: Consensus Recommendation for PET/MRI in Oncology – Aug 28, 2023
A consensus recommendation for PET/MRI in oncologic imaging in adults has been released by the SNMMI, the EANM, and the ISMRM.
SNMMI Supports CMSs Proposed Changes to Beta-Amyloid PET Coverage – Aug 22, 2023
SNMMI submitted comments to CMS in response to its proposed removal of the current NCD for beta-amyloid PET.
Journals – Aug 18, 2023
Learn more about journals published by or sponsored by the Society of Nuclear Medicine and Molecular Imaging.
Lantheus to Discontinue Production of Azedra – Aug 18, 2023
Lantheus will discontinue production of Azedra (iobenguane I-131), its FDA-approved therapy for pheochromocytoma/paraganglioma (PPGL).
PSMA PET/CT Waives the Need for Pre-Imaging Biopsy in Elderly Patients – Aug 14, 2023
In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid in therapy selection without the need for a biopsy, according to new research published in JNM.
SNMMI Announces Ones to Watch 2023 Selections – Aug 7, 2023
SNMMI is pleased to present our annual list of 30 early career professionals selected as Ones to Watch in 2023!
Clinical Trials Network – Aug 3, 2023
The SNMMI Clinical Trials Network provides tools and resources to promote faster, more cost-effective drug development and increase the availability and performance of molecular imaging radiopharmaceuticals for use in the clinic. Increased standardization in trials leads to better data that then results in expanded utilization of radiopharmaceuticals.
Message from the President – Jul 26, 2023
Since the Annual Meeting, SNMMI has been hard at work increasing access to nuclear medicine, planning for upcoming meetings, strengthening its relationships with colleagues around the world, and working with members to develop programs that meet their wants and needs.

Displaying 51 to 60 of 275 records
Page: << Prev 3… 4… 5… 6… 7… 8… 9… Next >>